Page last updated: 2024-09-04

tariquidar and Hypoxia

tariquidar has been researched along with Hypoxia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azab, AK; Azab, F; de la Puente, P; Federico, C; Fiala, M; Kusdono, HD; Muz, B; Salama, NN; Vij, R	1

Other Studies

1 other study(ies) available for tariquidar and Hypoxia

Article	Year
Tariquidar sensitizes multiple myeloma cells to proteasome inhibitors via reduction of hypoxia-induced P-gp-mediated drug resistance. Leukemia & lymphoma, 2017, Volume: 58, Issue:12 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Bortezomib; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Gene Expression; Gene Expression Profiling; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Multiple Myeloma; Oligopeptides; Proteasome Inhibitors; Quinolines	2017

Article

Year

Tariquidar sensitizes multiple myeloma cells to proteasome inhibitors via reduction of hypoxia-induced P-gp-mediated drug resistance.

Leukemia & lymphoma, 2017, Volume: 58, Issue:12

Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Bortezomib; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Gene Expression; Gene Expression Profiling; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Multiple Myeloma; Oligopeptides; Proteasome Inhibitors; Quinolines

2017